CLINICAL_TRIALS
research
· 2026-01-22
Clinical Trial Update: Relaxin Therapy for Atrial Fibrillation [Phase 1, Phase 2]
Summary
A clinical trial update describes Phase 1/2 testing of relaxin therapy for atrial fibrillation and related cardiovascular conditions, with the study currently n…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Deeptankar DeMazumder | Conditions: Atrial Fibrillation (AF), Arrhythmia | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING